Parallel Ridge Pattern Signals Acral Melanoma Risk - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Parallel Ridge Pattern Signals Acral Melanoma Risk

Meta-analysis supports multi-feature dermoscopic evaluation.

  • By

  • Andrea Surnit

  • April 28, 2026

  • 3 min

Share

Clinical Scorecard: Parallel Ridge Pattern Signals Acral Melanoma Risk

At a Glance

CategoryDetail
ConditionAcral Lentiginous Melanoma
Key MechanismsDermoscopic features including parallel ridge and multicomponent patterns indicate malignancy.
Target PopulationPatients with acral lesions, particularly those with darker skin types.
Care SettingDermatology clinics and cancer centers.

Key Highlights

  • Parallel ridge pattern shows 80% sensitivity and 99.4% specificity for melanoma.
  • Multicomponent patterns occur in 45.8% of melanomas, indicating high specificity.
  • Parallel furrow and latticelike patterns are more common in benign lesions.
  • No single dermoscopic feature identifies all melanomas; a multi-feature approach is recommended.
  • Fibrillar patterns are not statistically associated with malignancy.

Guideline-Based Recommendations

Diagnosis

  • Utilize a hierarchical, multi-feature approach for evaluating acral lesions.

Management

  • Consider lesions with parallel ridge or multicomponent features as suspicious for melanoma.

Monitoring & Follow-up

  • Regularly assess dermoscopic features in patients with acral lesions.

Risks

  • Approximately 20% of acral lentiginous melanomas may lack the parallel ridge pattern.

Patient & Prescribing Data

Individuals with acral nevi, particularly those with darker skin types.

Further research is needed to understand the implications of dermoscopic patterns in diverse populations.

Clinical Best Practices

  • Incorporate findings from the expanded 3-step dermoscopic algorithm.
  • Interpret dermoscopic patterns within the broader clinical context.

Related Resources & Content

Original Source(s)

Parallel Ridge Pattern Signals Acral Melanoma Risk

  • by Andrea Surnit

  • April 28, 2026

Related Content

Study explores adding a low-dose, daily oral chemotherapy for patients with melanoma

UCI Health medical oncologist Poorva Vaidya, MD is currently offering a new clinical trial sponsored by the UC Irvine Anti-Cancer Challenge, and lead by Warren Chow, MD, aimed at tackling a persistent challenge in melanoma care if patients fail first-line immunotherapy.

  • June 24, 2026

  • 1 min
High progesterone may be tied to syringoma

Elevated levels occurred in 29% of women with the condition compared with 6% of controls in a cross-sectional study.

10 states that support physician work-life balance

These 10 states have paid family or medical leave programs and health, wellness, peer support, or monitoring resources available to physicians or other health professionals.